New drug shows promise for painful skin condition in major trial

NCT ID NCT04242446

Summary

This completed Phase 3 trial tested whether the drug bimekizumab could reduce painful skin lesions and improve quality of life for people with moderate to severe hidradenitis suppurativa (HS), a chronic inflammatory skin disease. The study involved 505 adults whose HS did not respond well to antibiotics. Participants received either bimekizumab or a placebo for 16 weeks, and researchers measured changes in lesion counts, skin pain, and daily life impact.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIDRADENITIS SUPPURATIVA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Hs0003 20088

    Tel Aviv, Israel

  • Hs0003 20089

    Haifa, Israel

  • Hs0003 30011

    East Melbourne, Australia

  • Hs0003 30012

    Woolloongabba, Australia

  • Hs0003 30015

    Campbelltown, Australia

  • Hs0003 30016

    Carlton, Australia

  • Hs0003 30017

    Kogarah, Australia

  • Hs0003 40002

    Leuven, Belgium

  • Hs0003 40004

    Brussels, Belgium

  • Hs0003 40049

    Seville, Spain

  • Hs0003 40050

    Istanbul, Turkey (Türkiye)

  • Hs0003 40053

    Ankara, Turkey (Türkiye)

  • Hs0003 40060

    Liège, Belgium

  • Hs0003 40121

    Brussels, Belgium

  • Hs0003 40127

    Aarhus N, Denmark

  • Hs0003 40132

    Nice, France

  • Hs0003 40174

    Mainz, Germany

  • Hs0003 40177

    Münster, Germany

  • Hs0003 40197

    Amiens, France

  • Hs0003 40230

    Valencia, Spain

  • Hs0003 40246

    Saint-Mandé, France

  • Hs0003 40248

    Bochum, Germany

  • Hs0003 40249

    Kiel, Germany

  • Hs0003 40251

    Athens, Greece

  • Hs0003 40252

    Thessaloniki, Greece

  • Hs0003 40253

    Athens, Greece

  • Hs0003 40257

    Roma, Italy

  • Hs0003 40258

    Rozzano, Italy

  • Hs0003 40261

    Catania, Italy

  • Hs0003 40263

    Roma, Italy

  • Hs0003 40264

    Rotterdam, Netherlands

  • Hs0003 40266

    Badalona, Spain

  • Hs0003 40270

    Antalya, Turkey (Türkiye)

  • Hs0003 40271

    Izmir, Turkey (Türkiye)

  • Hs0003 40272

    Istanbul, Turkey (Türkiye)

  • Hs0003 40273

    Gaziantep, Turkey (Türkiye)

  • Hs0003 40285

    Toulon, France

  • Hs0003 40288

    Darmstadt, Germany

  • Hs0003 40292

    Groningen, Netherlands

  • Hs0003 40294

    Las Palmas de Gran Canaria, Spain

  • Hs0003 40295

    Pontevedra, Spain

  • Hs0003 40318

    Rouen, France

  • Hs0003 40323

    München, Germany

  • Hs0003 40324

    Dresden, Germany

  • Hs0003 40325

    Berlin, Germany

  • Hs0003 40327

    Bonn, Germany

  • Hs0003 40330

    Torino, Italy

  • Hs0003 40331

    Terracina, Italy

  • Hs0003 40332

    Trondheim, Norway

  • Hs0003 40337

    Bern, Switzerland

  • Hs0003 40342

    Angers, France

  • Hs0003 40351

    Breda, Netherlands

  • Hs0003 40355

    Le Mans, France

  • Hs0003 40357

    Magdeburg, Germany

  • Hs0003 40406

    Geneva, Switzerland

  • Hs0003 50008

    Johnston, Rhode Island, 02919, United States

  • Hs0003 50133

    Surrey, Canada

  • Hs0003 50137

    East Windsor, New Jersey, 08520, United States

  • Hs0003 50138

    Columbus, Ohio, 43213, United States

  • Hs0003 50140

    Birmingham, Alabama, 35233, United States

  • Hs0003 50141

    Tampa, Florida, 33613, United States

  • Hs0003 50142

    Nashville, Tennessee, 37215, United States

  • Hs0003 50146

    Boston, Massachusetts, 02215, United States

  • Hs0003 50147

    Hershey, Pennsylvania, 17033, United States

  • Hs0003 50149

    San Antonio, Texas, 78213, United States

  • Hs0003 50151

    Chapel Hill, North Carolina, 27516, United States

  • Hs0003 50153

    Ormond Beach, Florida, 32174, United States

  • Hs0003 50161

    Los Angeles, California, 90045, United States

  • Hs0003 50166

    Dallas, Texas, 75246, United States

  • Hs0003 50173

    St. John's, Canada

  • Hs0003 50175

    Phoenix, Arizona, 85006, United States

  • Hs0003 50177

    Cincinnati, Ohio, 45219, United States

  • Hs0003 50180

    Providence, Rhode Island, 02903, United States

  • Hs0003 50190

    Richmond Hill, Canada

  • Hs0003 50192

    Saskatoon, Canada

  • Hs0003 50194

    Omaha, Nebraska, 68144, United States

  • Hs0003 50198

    Beverly, Massachusetts, 01915, United States

  • Hs0003 50201

    Arlington, Texas, 76011, United States

  • Hs0003 50204

    Tulsa, Oklahoma, 74135, United States

  • Hs0003 50205

    North Miami Beach, Florida, 33162-4708, United States

  • Hs0003 50208

    Las Vegas, Nevada, 89148, United States

  • Hs0003 50210

    Atlanta, Georgia, 30309, United States

  • Hs0003 50220

    San Diego, California, 92123, United States

  • Hs0003 50233

    Barrie, Canada

  • Hs0003 50235

    New York, New York, 10003, United States

  • Hs0003 50270

    Seattle, Washington, 98101, United States

  • Hs0003 50280

    Watkinsville, Georgia, 30677, United States

  • Hs0003 50425

    Murray, Kentucky, 42071, United States

Conditions

Explore the condition pages connected to this study.